BioVie (BIVI) 10-K2022 FY Annual report

Filed: 27 Sep 22, 5:16pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: abatement, Abraham, accretion, Adam, Addiction, allocating, Alto, Amyotrophic, Anderson, arrive, assumption, attest, AVOPI, AVOPII, Bachelor, Berkeley, bifunctional, bifurcate, bifurcation, biodegradable, biology, bioorganic, blockchain, BSA, budget, budgeted, Cantor, captured, Carson, Casper, center, Cephalon, cerebral, chain, Christopher, cited, Columbo, comfort, compostable, Concerta, CRL, CSF, decade, dehydroepiandrosterone, delegate, delegated, delivery, demographic, deposit, desk, Developmental, Diary, DNA, Doctor, edaravone, eighteen, eleven, entertainment, enzymology, EVERSANA, EVP, Exploratory, Fellow, Fitzgerald, Fordham, forfeited, Forty, Franchise, furnish, furnished, gender, Greenwich, Guarantor, HCL, head, headquarter, Hewlet, Houston, Hybritch, implicit, indirect, insider, insight, Invega, Irvine, Johnson, joint, Jordan, Joseph, Journal, Lane, leadership, lesser, lien, London, match, mathematical, MCI, metabolome, methylphenidate, microbiology, Mitsubishi, mobility, modification, monoclonal, monotherapy, month, neuroimaging, Nye, OfferingSM, Ontrak, OPRX, Packard, paliperidone, Palo, Palumbo, permissible, pharmacological, Pharmanet, premium, prepayment, prime, profession, Professor, prorated, Psychiatry, Radicava, ratably, ratification, reinstated, relaxed, relocated, remeasured, remeasurement, rendered, rental, replication, Restated, resubmission, Ribicoff, Riley, Risperdal, risperidone, ROU, RSU, sat, SDSU, Sheldon, Shoreham, short, Social, Society, spinal, sterol, struck, surge, Symptom, synthetic, systemix, Tanabe, ThinkEquity, timeline, top, traditionally, Training, UC, UK, Underwriting, unexercised, Unified, unvested, venture, verbal, Verde, visual, VP, Wall, Washington, worth, Yale, ZipMo, Zynerba

Removed: amend, Article, cancelled, commercializing, directing, district, easy, enforceable, executed, forgiven, inter, IPR, killing, Motion, nonalcoholic, notice, patentability, petitioned, prepare, printed, properly, PTAB, revised, save, Ste, titled, unanticipated, valid

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

BIVI similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S. C. SECTION 1350 AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Biovie Inc., (the “Company”) on Form 10-K for the year ended June 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Joanne Wendy Kim, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002, that, to my knowledge:

(1)	The Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m (a) or 78o(d)); and

(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: September 27, 2022

/s/ Joanne Wendy Kim

Joanne Wendy Kim

Chief Financial Officer
(Principal Financial and Accounting Officer)